Abbott Laboratories (NYSE:ABT) Price Target Raised to $136.00 at Evercore ISI
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by Evercore ISI to $136.00 in a report released on Thursday morning,Stock Target Advisor reports. They currently have a buy rating on the healthcare product maker’s stock.
Evercore ISI expressed on Friday that Wall Street will likely see more of what it experienced in 2024 as the investment ...
Evercore ISI anticipates a 22% growth in the S&P 500 Index to 7,200, up from its current level of 5,940, therefore signaling ...
David Palmer, Evercore ISI, joins 'Squawk on the Street' to discuss his outlook for restaurants in 2025. Polar Vortex Map ...
Evercore ISI lowered the firm’s price target on Tractor Supply (TSCO) to $58 from $290 and keeps an In Line rating on the shares as the firm ...
Evercore (NYSE: EVR) will host its 11th annual Utility CEO Conference in Scottsdale, Arizona, Jan. 8-10, 2025.
Evercore examined Microsoft's past performance as well, noting four times over the past four years when the company lagged ...
On Thursday, Carvana Co (CVNA) stock saw a decline, ending the day at $199.56 which represents a decrease of $-3.80 or -1.87% from the prior close of $203.36. The stock opened at $200.71 and touched a ...
Analysts at Evercore ISI highlight the challenges posed by the U.S. 10-year Treasury yield (TLT), which has risen to key thresholds of 4.5%, 4.75%, and 5%, creating pressure on equities and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback